Intervention Group for Oxytocics

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Reproductive Medicine Associates of New Jersey, Basking Ridge, NJ
Oxytocics+1 More
Platelet Rich Plasma Intrauterine infusion - Other
Eligibility
18 - 65
Female
What conditions do you have?
Select

Study Summary

To determine the effectiveness of an intrauterine PRP infusion on endometrial thickness and in vitro fertilization (IVF) outcomes in a population of infertile women with a history of unresponsive thin endometrium.

Eligible Conditions

  • Oxytocics

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: during the proliferative phase of the frozen embryo transfer cycle

Week 9
Sustained implantation rate
during the proliferative phase of the frozen embryo transfer cycle
Endometrial Thickness during frozen embryo transfer

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Intervention Group
1 of 2
Control Group
1 of 2
Active Control
Non-Treatment Group

62 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention Group · Has Placebo Group · N/A

Intervention Group
Other
ActiveComparator Group · 1 Intervention: Platelet Rich Plasma Intrauterine infusion · Intervention Types: Other
Control Group
Other
PlaceboComparator Group · 1 Intervention: Normal saline Intrauterine infusion · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: during the proliferative phase of the frozen embryo transfer cycle
Closest Location: Reproductive Medicine Associates of New Jersey · Basking Ridge, NJ
Photo of new jersey 1Photo of new jersey 2Photo of new jersey 3
2015First Recorded Clinical Trial
0 TrialsResearching Oxytocics
27 CompletedClinical Trials

Who is running the clinical trial?

Reproductive Medicine Associates of New JerseyLead Sponsor
48 Previous Clinical Trials
38,358 Total Patients Enrolled

Eligibility Criteria

Age 18 - 65 · Female Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Patients who have previously undergone at least 2 unsuccessful frozen embryo transfer cycles, defined as failure to achieve a sustained clinical pregnancy (visualization of intrauterine gestational sac on ultrasound or a cancelled embryo transfer cycle due to inadequate endometrial thickness.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.